首页|康复新液在消化内镜术后患者中应用效果和安全性的Meta分析

康复新液在消化内镜术后患者中应用效果和安全性的Meta分析

扫码查看
目的 系统评价康复新液联合常规治疗在消化内镜术后患者中的应用效果与安全性。方法 计算机检索 PubMed、Embase、Cochrane Library、CNKI、WanFang Data、VIP数据库,搜集关于消化内镜术后应用康复新液的随机对照试验(RCT),检索时限均从建库至2023年12月31日,由2名研究者独立筛选文献、提取数据并评价纳入研究的偏倚风险后,使用RevMan 5。3和Stata 14软件进行Meta分析。结果 共纳入14个RCT,包括1359例患者。Meta分析结果显示,与常规治疗组相比,康复新液联用组可以提高术后溃疡完全愈合率[RR=1。32,95%CI(1。07,1。61),P=0。009]、术后临床症状缓解率[RR=1。20,95%CI(1。13,1。27),P<0。001],但2组的不良反应发生率差异无统计学意义(P>0。05)。亚组分析显示,康复新液联用组术后2周的溃疡完全愈合率高于常规治疗组[RR=1。56,95%CI(1。28,1。92),P<0。001],但2组术后4周的溃疡完全愈合率差异无统计学意义(P>0。05);康复新液口服给药组[RR=1。19,95%CI(1。11,1。27),P<0。001]或经内镜外用喷洒给药组[RR=1。23,95%CI(1。09,1。39),P<0。001]的临床症状缓解率均高于常规治疗组。结论 消化内镜术后常规用药基础上联合康复新液治疗可进一步提高患者的临床疗效,尤其是促进术后2周内溃疡完全愈合、缓解术后临床症状方面效果较好,但能否降低药品不良反应发生率的证据不足。受纳入研究数量和质量的限制,上述结论尚待更多高质量研究予以验证。
Efficacy and safety of Kangfuxin liquid in postoperative gastrointestinal endoscopy patients:a Meta-analysis
Objective To systematically evaluate the efficacy and safety of Kangfuxin liquid combined with conventional treatment in postoperative patients with gastrointestinal endoscopy.Methods PubMed,Embase,Cochrane Library,CNKI,WanFang Data,VIP databases were electronically searched to collect randomized controlled trials(RCTs)about Kangfuxin liquid combined with conventional treatment versus conventional treatment for postoperative complications of gastrointestinal endoscopy,from inception to December 31,2023.Two reviewers independently screened literature,extracted data and assessed the risk of bias in the included studies.Meta-analysis was then performed by using RevMan 5.3 software and Stata 14 software.Results A total of 14 RCTs involving 1 359 patients were included.The results of Meta-analysis showed that compared with the conventional treatment group,the Kangfuxin liquid combination group could improve postoperative ulcer complete healing rate(RR=1.32,95%CI 1.07 to 1.61,P=0.009)and postoperative clinical symptomatic relief rate(RR=1.20,95%CI 1.13 to 1.27,P<0.001),but there was no statistically significant difference in the incidence of adverse reactions between the two groups(P>0.05).Subgroup analyses showed that the ulcer complete healing rate in the Kangfuxin liquid combination group was higher than that in the conventional treatment group at 2 weeks postoperatively(RR=1.56,95%CI 1.28 to 1.92,P<0.001),but there was no statistically significant difference in ulcer complete healing rate between the two groups at 4 weeks postoperatively(P>0.05);the efficacy of oral administration(RR=1.19,95%CI 1.11 to 1.27,P<0.001)and transendoscopic topical spray administration(RR=1.23,95%CI 1.09 to 1.39,P<0.001)of Kangfuxin liquid groups were better than those of the conventional treatment group in relieving postoperative clinical symptoms.Conclusion Combining Kangfuxin liquid treatment with conventional medication after gastrointestinal endoscopy may further improve clinical efficacy,especially in promoting the ulcer complete healing within 2 weeks after surgery and relieving postoperative clinical symptoms,but there is insufficient evidence on whether it reduces the incidence of adverse effects.Due to the limitations of the number and quality of included studies,the above conclusions are yet to be validated by more high-quality studies.

Kangfuxin liquidGastrointestinal endoscopyPostoperative efficacyMeta-analysisRandomized controlled trial

赵冰、蔡萌强、崔玉容、刘君颖

展开 >

河南中医药大学第一附属医院脾胃肝胆科(郑州 450008)

河南中医药大学第一临床医学院(郑州 450008)

康复新液 消化内镜 术后疗效 Meta分析 随机对照试验

河南省科技攻关项目

222102310293

2024

药物流行病学杂志
中国药学会 武汉医药(集团)股份有限公司

药物流行病学杂志

CSTPCD
影响因子:0.746
ISSN:1005-0698
年,卷(期):2024.33(6)